When Gln addiction is disrupted due to Gln deprivation, the invasive and metastatic capabilities of tumor cells are significantly diminished
246 Despite these promising results, liver-targeting specificity remains uncertain, and large-scale clinical validation is lacking
In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
outcomes are individual and not guaranteed
doi: 10.1021/jf072612+
Of note, increased CGRP content has been found in the airway submucosal glands of humans with CF, as well as in mice, ferrets, and pigs with CF [161]